...
首页> 外文期刊>Vascular and endovascular surgery >Vascular medicine: periprocedural hypertension: current concepts in management for the vascular surgeon.
【24h】

Vascular medicine: periprocedural hypertension: current concepts in management for the vascular surgeon.

机译:血管药物:围手术期高血压:血管外科医生当前的治疗理念。

获取原文
获取原文并翻译 | 示例
           

摘要

Periprocedural hypertension is a common finding in patients undergoing vascular surgery or endovascular procedures, and this may pose a risk for subsequent cardiovascular morbidity or mortality. Accordingly, the vascular surgeon who wishes to improve outcomes needs to be proficient not only in surgical technique but also in the medical management of the patient's associated conditions, especially hypertension. Vascular procedures need not be cancelled unless the blood pressure (BP) is more than 180 mm Hg systolic or 110 mm Hg diastolic, but attention should also be paid to evidence of end organ damage in making this decision. In most cases preoperative antihypertensive medications should be continued up till the procedure. Postoperative hypertension may require 1 of a number of intravenous medications, which are listed. Oral nifedipine should generally be avoided for fear of inducing an uncontrolled hypotensive response and cardiac ischemia.
机译:围手术期高血压是接受血管外科手术或血管内手术的患者的常见发现,这可能会导致随后的心血管疾病或死亡的风险。因此,希望改善结果的血管外科医师不仅需要精通手术技术,而且还需要精通患者相关疾病尤其是高血压的医疗管理。除非血压(BP)收缩压超过180 mm Hg或舒张压超过110 mm Hg,否则不必取消血管手术,但在做出此决定时也应注意终末器官损害的证据。在大多数情况下,术前应服用降压药直至手术。术后高血压可能需要多种静脉药物中的一种。一般应避免口服硝苯地平,以免引起无法控制的降压反应和心脏缺血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号